High-Content Surface and Total Expression siRNA Kinase Library Screen with VX-809 Treatment Reveals Kinase Targets that Enhance F508del-CFTR Rescue

[Image: see text] The most promising F508del-CFTR corrector, VX-809, has been unsuccessful as an effective, stand-alone treatment for CF patients, but the rescue effect in combination with other drugs may confer an acceptable level of therapeutic benefit. Targeting cellular factors that modify traff...

Descripción completa

Detalles Bibliográficos
Autores principales: Perkins, Lydia A., Fisher, Gregory W., Naganbabu, Matharishwan, Schmidt, Brigitte F., Mun, Frederick, Bruchez, Marcel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844356/
https://www.ncbi.nlm.nih.gov/pubmed/29384380
http://dx.doi.org/10.1021/acs.molpharmaceut.7b00928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844356/
https://www.ncbi.nlm.nih.gov/pubmed/29384380
http://dx.doi.org/10.1021/acs.molpharmaceut.7b00928

Ejemplares similares